Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cobas HCV

K-Number: K221007 · 2022-11-04

Decision Date2022-11-04
Product CodeMZP
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

cobas HCV is a medical device manufactured by Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 2022-11-04 under approval number K221007. The device is classified under product code MZP. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cobas HCV?

cobas HCV is a medical device that received FDA 510(k) clearance on 2022-11-04. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K221007.

When was cobas HCV approved by the FDA?

cobas HCV received FDA 510(k) clearance on 2022-11-04, under approval number K221007.

What company makes cobas HCV?

cobas HCV is manufactured by Roche Molecular Systems, Inc..

What is the FDA product code for cobas HCV?

The FDA product code for cobas HCV is MZP.

Other Devices by Roche Molecular Systems, Inc.

View all 47 devices →

Related Devices (Code: MZP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.